Lu K - Search Results

1

Targeted PI3K/AKT/mTOR therapy for metastatic carcinomas of the cervix: A phase I clinical experience.

Hou MM, Liu X, Wheler J, Naing A, Hong D, Coleman RL, Tsimberidou A, Janku F, Zinner R, Lu K, Kurzrock R, Fu S. Hou MM, et al. Among authors: lu k. Oncotarget. 2014 Nov 30;5(22):11168-79. doi: 10.18632/oncotarget.2584. Oncotarget. 2014. PMID: 25426553 Free PMC article. Clinical Trial.

2

Loss of phosphatase and tensin homologue deleted on chromosome 10 and phosphorylation of mammalian target of rapamycin are associated with progesterone refractory endometrial hyperplasia.

Milam MR, Soliman PT, Chung LH, Schmeler KM, Bassett RL Jr, Broaddus RR, Lu KH. Milam MR, et al. Among authors: lu kh. Int J Gynecol Cancer. 2008 Jan-Feb;18(1):146-51. doi: 10.1111/j.1525-1438.2007.00958.x. Epub 2007 Apr 26. Int J Gynecol Cancer. 2008. PMID: 17466036

3

Phase I clinical trials in 85 patients with gynecologic cancer: the M. D. Anderson Cancer Center experience.

Moroney J, Wheler J, Hong D, Naing A, Falchook G, Bodurka D, Coleman R, Lu K, Xiao L, Kurzrock R. Moroney J, et al. Among authors: lu k. Gynecol Oncol. 2010 Jun;117(3):467-72. doi: 10.1016/j.ygyno.2010.02.008. Epub 2010 Mar 26. Gynecol Oncol. 2010. PMID: 20347123 Free PMC article. Clinical Trial.

4

Advanced gynecologic malignancies treated with a combination of the VEGF inhibitor bevacizumab and the mTOR inhibitor temsirolimus.

Piha-Paul SA, Wheler JJ, Fu S, Levenback C, Lu K, Falchook GS, Naing A, Hong DS, Tsimberidou AM, Kurzrock R. Piha-Paul SA, et al. Among authors: lu k. Oncotarget. 2014 Apr 15;5(7):1846-55. doi: 10.18632/oncotarget.1834. Oncotarget. 2014. PMID: 24742900 Free PMC article. Clinical Trial.

5

Outcomes of patients with metastatic cervical cancer in a phase I clinical trials program.

Hou MM, Liu X, Wheler J, Naing A, Hong D, Bodurka D, Schmeler K, Tsimberidou A, Janku F, Zinner R, Piha-Paul S, Hu CY, Lu K, Kurzrock R, Fu S. Hou MM, et al. Among authors: lu k. Anticancer Res. 2014 May;34(5):2349-55. Anticancer Res. 2014. PMID: 24778042

6

Continuous anti-angiogenic therapy after tumor progression in patients with recurrent high-grade epithelial ovarian cancer: phase I trial experience.

Hou MM, Wang Z, Janku F, Piha-Paul S, Naing A, Hong D, Westin S, Coleman RL, Sood AK, Tsimberidou AM, Subbiah V, Wheler J, Zinner R, Lu K, Meric-Bernstam F, Fu S. Hou MM, et al. Among authors: lu k. Oncotarget. 2016 Jun 7;7(23):35132-43. doi: 10.18632/oncotarget.9048. Oncotarget. 2016. PMID: 27147567 Free PMC article.

7

Characteristics and outcomes for patients with advanced vaginal or vulvar cancer referred to a phase I clinical trials program: the MD Anderson cancer center experience.

Fu S, Shi N, Wheler J, Naing A, Janku F, Piha-Paul S, Gong J, Hong D, Tsimberidou A, Zinner R, Subbiah V, Hou MM, Ramirez P, Ramondetta L, Lu K, Meric-Bernstam F. Fu S, et al. Among authors: lu k. Gynecol Oncol Res Pract. 2015 Nov 14;2:10. doi: 10.1186/s40661-015-0018-x. eCollection 2015. Gynecol Oncol Res Pract. 2015. PMID: 27231570 Free PMC article.

8

Multi-disciplinary summit on genetics services for women with gynecologic cancers: A Society of Gynecologic Oncology White Paper.

Randall LM, Pothuri B, Swisher EM, Diaz JP, Buchanan A, Witkop CT, Bethan Powell C, Smith EB, Robson ME, Boyd J, Coleman RL, Lu K. Randall LM, et al. Among authors: lu k. Gynecol Oncol. 2017 Aug;146(2):217-224. doi: 10.1016/j.ygyno.2017.06.002. Epub 2017 Jun 7. Gynecol Oncol. 2017. PMID: 28596016

9

Multicenter Phase II Trial of the WEE1 Inhibitor Adavosertib in Refractory Solid Tumors Harboring CCNE1 Amplification.

Fu S, Yao S, Yuan Y, Previs RA, Elias AD, Carvajal RD, George TJ, Yuan Y, Yu L, Westin SN, Xing Y, Dumbrava EE, Karp DD, Piha-Paul SA, Tsimberidou AM, Ahnert JR, Takebe N, Lu K, Keyomarsi K, Meric-Bernstam F. Fu S, et al. Among authors: lu k. J Clin Oncol. 2023 Mar 20;41(9):1725-1734. doi: 10.1200/JCO.22.00830. Epub 2022 Dec 5. J Clin Oncol. 2023. PMID: 36469840 Free PMC article. Clinical Trial.

10

Clinical and genomic landscape of RAS mutations in gynecologic cancers.

Son J, Zhang Y, Lin H, Mirallas O, Alvarez Ballesteros P, Nardo M, Clark N, Hillman RT, Campbell E, Holla V, Johnson AM, Biter AB, Yuan Y, Cobb LP, Gershenson DM, Jazaeri AA, Lu KH, Soliman PT, Westin SN, Euscher ED, Lawson BC, Yang RK, Meric-Bernstam F, Hong DS. Son J, et al. Among authors: lu kh. Clin Cancer Res. 2024 Apr 30. doi: 10.1158/1078-0432.CCR-23-2819. Online ahead of print. Clin Cancer Res. 2024. PMID: 38687597

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,726 results

Search Page